Winston & Strawn represented Picard Medical in connection with the closing of its $17 million initial public offering of 4,250,000 shares of common stock at a public offering price of $4.00 per share. The shares began trading on the NYSE American on Aug. 29, 2025.
The attorneys from Winston & Strawn include:
- Mike Blankenship, Lead Partner, Houston
- Ben Smolij, Partner, Houston
- Andrew Homann, Associate, Dallas
- David Houck, Associate, Dallas
- Emily Semon, Associate, Dallas
- Alexandra Santana, Associate, Houston
- Marissa Sims, Associate, Chicago
